AMWatch

Novo Holding-selskab styrer mod børsen

Biotekselskabet Symphogen kan til efteråret være at finde på de danske børslister. En beslutning om en mulig børsnotering træffes efter sommerferien.

Photo: Symphogen/PR

18 år efter stiftelsen kan biotekselskabet Symphogen efter flere års opvarmning nu være på vej til Københavns Fondsbørs.

Det kan ske allerede til efteråret, siger selskabets adm. direktør Martin Olin Andersen til Dagbladet Børsen.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

Savills IM working hard on first Nordic residential investment

The global property investor has plans to expand its growing portfolio in Denmark with a new asset class, residential real estate, "very soon," says Head of Nordics Peter Broström. The manager still believes in the office and retail sectors, despite the pandemic and rising inflation.

Latest news

Jobs

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch